[go: up one dir, main page]

DE69807104D1 - Formulierungen mit gesteuerter freisetzung - Google Patents

Formulierungen mit gesteuerter freisetzung

Info

Publication number
DE69807104D1
DE69807104D1 DE69807104T DE69807104T DE69807104D1 DE 69807104 D1 DE69807104 D1 DE 69807104D1 DE 69807104 T DE69807104 T DE 69807104T DE 69807104 T DE69807104 T DE 69807104T DE 69807104 D1 DE69807104 D1 DE 69807104D1
Authority
DE
Germany
Prior art keywords
film
composition
forming
controlled release
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69807104T
Other languages
English (en)
Other versions
DE69807104T2 (de
Inventor
Michael Newton
Fung Siew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alizyme Therapeutics Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd filed Critical BTG International Ltd
Publication of DE69807104D1 publication Critical patent/DE69807104D1/de
Application granted granted Critical
Publication of DE69807104T2 publication Critical patent/DE69807104T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69807104T 1997-10-23 1998-10-23 Formulierungen mit gesteuerter freisetzung Expired - Lifetime DE69807104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722426.5A GB9722426D0 (en) 1997-10-23 1997-10-23 Controlled release formulations
PCT/GB1998/003178 WO1999021536A1 (en) 1997-10-23 1998-10-23 Controlled release formulations

Publications (2)

Publication Number Publication Date
DE69807104D1 true DE69807104D1 (de) 2002-09-12
DE69807104T2 DE69807104T2 (de) 2002-12-05

Family

ID=10820995

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69807104T Expired - Lifetime DE69807104T2 (de) 1997-10-23 1998-10-23 Formulierungen mit gesteuerter freisetzung

Country Status (10)

Country Link
US (1) US6534549B1 (de)
EP (1) EP1024795B1 (de)
JP (2) JP2001520986A (de)
AT (1) ATE221773T1 (de)
CA (1) CA2302585C (de)
DE (1) DE69807104T2 (de)
DK (1) DK1024795T3 (de)
ES (1) ES2178268T3 (de)
GB (1) GB9722426D0 (de)
WO (1) WO1999021536A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6929884B2 (en) * 2001-04-19 2005-08-16 Zinc Matrix Power, Inc. Method for manufacture of films containing insoluble solids embedded in cellulose-based films
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
FR2862654B1 (fr) * 2003-11-20 2006-02-10 Roquette Freres Composition amylacee filmogene
EP1547601A1 (de) * 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
KR20070112289A (ko) * 2005-03-16 2007-11-22 프로사이트 코포레이션 노화 또는 광손상된 피부를 예방하고 치료하기 위한 방법및 조성물
US20090017110A1 (en) * 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
US20090285863A1 (en) * 2006-07-27 2009-11-19 Gisela Fridrun Podczeck Coating Composition Comprising Starch
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
AU2009229167B2 (en) 2008-03-27 2014-01-23 Zpower, Llc Electrode separator
GB0808537D0 (en) * 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
FR2934467B1 (fr) * 2008-07-31 2014-08-22 Roquette Freres Forme solide pelliculee et procede de pelliculage a temperature ambiante.
EP2179727B1 (de) 2008-10-27 2013-05-29 Roquette Freres Folienbeschichtungen aus wasserunlöslichem Polymer und modifiziertem Stärkederivat zur Dickdarmansteuerung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
MX2011007393A (es) 2009-01-12 2011-10-06 Biokier Inc Composicion y metodo para el tratamiento de la diabetes.
CN102711800A (zh) 2009-09-23 2012-10-03 拜奥基尔公司 治疗糖尿病的组合物和方法
LT2482822T (lt) 2009-10-01 2018-09-10 Adare Pharmaceuticals, Inc. Geriamosios kortikosteroidų kompozicijos
US9963368B2 (en) 2010-11-15 2018-05-08 Archer Daniels Midland Company Microemulsions and uses thereof in dispersing catalysts
HUE036187T2 (hu) 2012-04-30 2018-06-28 Tillotts Pharma Ag Késleltetett leadású gyógyszerkészítmény
US20140271931A1 (en) * 2013-03-12 2014-09-18 Perosphere Inc. Anti-Acne Topical Films
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
BR122020013726B1 (pt) 2013-10-29 2022-11-01 Tillotts Pharma Ag Formulação de droga de liberação retardada
ES2994844T3 (en) 2018-12-07 2025-02-03 Tillotts Pharma Ag Colonic drug delivery formulation
EP3662900A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Kolonwirkstoffverabreichungsformulierung
EP3662898A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Feste formulierung enthaltend mesalazin
ES3002632T3 (en) 2018-12-07 2025-03-07 Tillotts Pharma Ag Delayed release drug formulation comprising an outerlayer with an enzymatically degradable polymer, its composition and its method of manufacturing
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
CA2302585C (en) 2007-09-25
EP1024795A1 (de) 2000-08-09
EP1024795B1 (de) 2002-08-07
DK1024795T3 (da) 2002-12-02
DE69807104T2 (de) 2002-12-05
GB9722426D0 (en) 1997-12-24
ATE221773T1 (de) 2002-08-15
US6534549B1 (en) 2003-03-18
JP2001520986A (ja) 2001-11-06
ES2178268T3 (es) 2002-12-16
WO1999021536A1 (en) 1999-05-06
CA2302585A1 (en) 1999-05-06
JP2010270335A (ja) 2010-12-02

Similar Documents

Publication Publication Date Title
DE69807104D1 (de) Formulierungen mit gesteuerter freisetzung
DE69832621D1 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von wirkstoffen
DE69434258D1 (de) Mikroverkapselte 1,2-benzazole
DE69407404D1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
KR930003906A (ko) 약학적 구상 제형
ATE217188T1 (de) Granulierte pharmazeutische zusammensetzung
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
ES2171471T3 (es) Sistema para la administracion oral de desferrioxamina.
ATE356614T1 (de) Veränderung der wirkstoffladung in multivesikulären liposomen
CA2304662A1 (en) Methods for fabricating polymer-based controlled release preparations
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
NO964410L (no) Matriks-pelleter med langsom frigiving, samt fremstilling av disse
ATE238813T1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
NO985094D0 (no) Polymerpulver som er redispergerbart i vandige l°sninger
AU3483497A (en) Solid solution of an antifungal agent with enhanced bioavailability
EP0297866A3 (de) Arzneimittel
MY133341A (en) Expandable vinyl chloride resin composition
JPS5312978A (en) Isolation of low-molecular weight polymers
JPS57142913A (en) Donor of physiologically active substance
JPS56142208A (en) Prolongable prostaglandin transvaginal agent and its preparation
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer
CA2258679A1 (en) Solid solution of an antifungal agent with enhanced bioavailability

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ALIZYME THERAPEUTICS LTD., GREAT ABINGTON, CAMBRID